422 related articles for article (PubMed ID: 28553668)
1. The clinical spectrum of Erdheim-Chester disease: an observational cohort study.
Estrada-Veras JI; O'Brien KJ; Boyd LC; Dave RH; Durham B; Xi L; Malayeri AA; Chen MY; Gardner PJ; Alvarado-Enriquez JR; Shah N; Abdel-Wahab O; Gochuico BR; Raffeld M; Jaffe ES; Gahl WA
Blood Adv; 2017 Feb; 1(6):357-366. PubMed ID: 28553668
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
[TBL] [Abstract][Full Text] [Related]
3. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm.
Haroche J; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
Expert Rev Clin Immunol; 2015; 11(9):1033-42. PubMed ID: 26197238
[TBL] [Abstract][Full Text] [Related]
4. Erdheim Chester disease in a patient with Burkitt lymphoma: a case report and review of literature.
Sakr HI; Buckley K; Baiocchi R; Zhao WJ; Hemminger JA
Diagn Pathol; 2018 Nov; 13(1):94. PubMed ID: 30474563
[TBL] [Abstract][Full Text] [Related]
5. Erdheim-Chester Disease: a comprehensive review of the literature.
Mazor RD; Manevich-Mazor M; Shoenfeld Y
Orphanet J Rare Dis; 2013 Sep; 8():137. PubMed ID: 24011030
[TBL] [Abstract][Full Text] [Related]
6. Dabrafenib and steroids for the treatment of Erdheim-Chester disease with extensive CNS involvement: a case report.
Yuen CA; Bao S; Aung MS; Shishodia R; Kong XT
Per Med; 2024; 21(2):71-78. PubMed ID: 38275171
[TBL] [Abstract][Full Text] [Related]
7. [Erdheim-Chester disease (ECD), an inflammatory myeloid neoplasia].
Haroche J; Papo M; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
Presse Med; 2017 Jan; 46(1):96-106. PubMed ID: 27234902
[TBL] [Abstract][Full Text] [Related]
8. Erdheim-Chester disease.
Campochiaro C; Tomelleri A; Cavalli G; Berti A; Dagna L
Eur J Intern Med; 2015 May; 26(4):223-9. PubMed ID: 25865950
[TBL] [Abstract][Full Text] [Related]
9. Erdheim-Chester disease with bilateral orbital masses and multi-systemic symptoms: two case reports.
Qiao J; Ma R; Peng X; He W
World J Surg Oncol; 2023 Jul; 21(1):233. PubMed ID: 37525276
[TBL] [Abstract][Full Text] [Related]
10. Erdheim-Chester disease: expanding the spectrum of cutaneous manifestations.
Kobic A; Shah KK; Schmitt AR; Goyal G; Go RS; Guo R; Rech KL; Sartori-Valinotti JC;
Br J Dermatol; 2020 Feb; 182(2):405-409. PubMed ID: 31120137
[TBL] [Abstract][Full Text] [Related]
11. Erdheim-Chester Disease With BRAF V600E Mutation and Central Diabetes Insipidus Successfully Treated With Glucocorticoid.
Imaizumi T; Daido H; Kato T; Yabe D
JCEM Case Rep; 2023 Mar; 1(2):luad014. PubMed ID: 37908458
[TBL] [Abstract][Full Text] [Related]
12. Erdheim-Chester disease: a comprehensive review from the ophthalmologic perspective.
Kanakis M; Petrou P; Lourida G; Georgalas I
Surv Ophthalmol; 2022; 67(2):388-410. PubMed ID: 34081930
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of intracranial Langerhans cell histiocytosis and Erdheim-Chester disease in a pediatric patient: a case report.
Kim S; Lee M; Shin HJ; Lee J; Suh YL
Childs Nerv Syst; 2016 May; 32(5):893-6. PubMed ID: 26466952
[TBL] [Abstract][Full Text] [Related]
14. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease.
Haroche J; Abla O
Hematology Am Soc Hematol Educ Program; 2015; 2015():571-8. PubMed ID: 26637774
[TBL] [Abstract][Full Text] [Related]
15. Erdheim-Chester disease.
Haroche J; Arnaud L; Cohen-Aubart F; Hervier B; Charlotte F; Emile JF; Amoura Z
Curr Rheumatol Rep; 2014 Apr; 16(4):412. PubMed ID: 24532298
[TBL] [Abstract][Full Text] [Related]
16. Hypoalphalipoproteinemia and BRAF
Cohen-Aubart F; Guerin M; Poupel L; Cluzel P; Saint-Charles F; Charlotte F; Arsafi Y; Emile JF; Frisdal E; Le Goff C; Donadieu J; Amoura Z; Lesnik P; Haroche J; Le Goff W
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1913-1925. PubMed ID: 29930009
[TBL] [Abstract][Full Text] [Related]
17. Erdheim-Chester Disease: The Importance of Information Integration.
Nikonova A; Esfahani K; Chausse G; Probst S; Petrogiannis-Haliotis T; Knecht H; Gyger G
Case Rep Oncol; 2017; 10(2):613-619. PubMed ID: 28868020
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous manifestations of Erdheim-Chester disease (ECD): Clinical, pathological, and molecular features in a monocentric series of 40 patients.
Chasset F; Barete S; Charlotte F; Cohen-Aubart F; Arnaud L; Le Pelletier F; Emile JF; Francès C; Amoura Z; Haroche J
J Am Acad Dermatol; 2016 Mar; 74(3):513-20. PubMed ID: 26785805
[TBL] [Abstract][Full Text] [Related]
19. Xanthomatous Inflammatory Infiltrate Involving the Spleen: An Unusual Presentation of Erdheim-Chester Disease and Review of the Literature.
Di Stefano G; Granai M; Giudici F; Roselli G; Lazzi S; Santi R
Am J Case Rep; 2021 Jun; 22():e931060. PubMed ID: 34083501
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Neuroimaging Manifestations of Erdheim-Chester Disease: A Review.
Garg N; Lavi ES
J Neuroimaging; 2021 Jan; 31(1):35-44. PubMed ID: 32920940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
